Back to Media Coverage

FDA APPROVES EXPANDED LABEL FOR INSIGHTEC’S ULTRASOUND UTERINE FIBROID DEVICE

NICOLE ORAN | October 8, 2015
icons for web-03.png

Israeli devicemaker INSIGHTEC has adapted the label for its ultrasound technology designed to treat uterine fibroids, the ExAblate device, in order for it to be available to women who want to keep their uterus intact while still having the option to get pregnant.

 

The FDA has now signed off on this label adjustment, which will allow the company to continue moving forward with funding for R&D. The expanded approval is based on clinical data from 118 pregnancies that occurred after women were treated with the device.

 

Read more

Media Contacts:

Please fill in the following details and we will get in touch with you. (* Required)

agreement Error

Thank You!

Thank you for contacting us! We will get back to you shortly.

Thank You!

This site is brought to you by INSIGHTEC, © 2018 INSIGHTEC Ltd. All rights reserved.

NGSoft logo